Sir William Dunn School of Pathology, University of Oxford, United Kingdom.
Am J Trop Med Hyg. 2012 Apr;86(4):561-5. doi: 10.4269/ajtmh.2012.11-0504.
Controlled human malaria infection by blood stage parasite (BSP) inoculation is an alternative to the well-established model of infection with Plasmodium falciparum sporozoites delivered by mosquito bites. The BSP model has been utilized less frequently, but its use is increasing. Advantages of BSP challenge include greater ease of administration, better standardization of the infecting dose per volunteer, and good inter-study reproducibility of in vivo parasite dynamics. Recently, a surprising reduction in clinical symptoms at microscopic patency in the BSP model has been identified, which has an undefined and intriguing pathophysiologic basis, but may make this approach more acceptable to volunteers. We summarize clinical, parasitologic, and immunologic data from all BSP challenges to date, explore differences between the BSP and sporozoite models, and propose future applications for BSP challenge.
经血液期寄生虫(BSP)接种控制的人类疟疾感染是替代通过蚊子叮咬传播的恶性疟原虫孢子虫感染的既定模型的另一种选择。BSP 模型的使用频率较低,但正在增加。BSP 挑战的优势包括给药更容易、每个志愿者感染剂量的标准化更好以及体内寄生虫动力学的研究间可重复性更好。最近,在 BSP 模型中发现了微小通透性时临床症状的惊人减少,其具有未定义和有趣的病理生理基础,但可能使这种方法更容易被志愿者接受。我们总结了迄今为止所有 BSP 挑战的临床、寄生虫学和免疫学数据,探讨了 BSP 和孢子虫模型之间的差异,并提出了 BSP 挑战的未来应用。